FDA

EDMOND, Okla. – May 13, 2025 -- Watkins-Conti Products, Inc. ("Watkins-Conti"), a company that develops innovative solutions for women's pelvic health, today announced the peer-reviewed publication of clinical trial results evaluating Yōni.Fit® Bladder Support ("Yōni.Fit®"). Designed and manufactured in the United States, Yōni.Fit® obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA) in 2024 for the temporary management of urine leakage caused by stress urinary incontinence (SUI) in women, 18 years and older.

The U.S. Food and Drug Administration is taking action to remove ingestible fluoride prescription drugs for children off the market. In a press release, the FDA said products that are swallowed offer significant risk to infants and toddlers, unlike toothpaste with fluoride or fluoride rinses. The FDA also said the ingestion of fluoride products comes with risks like problems with the early development of the gut microbiome in childhood, thyroid disorders, weight gain, and decreased IQ. The federal agency provided links to several studies that point to worrying effects in...

OpenAI has been connecting with various companies in an effort to incorporate its generative artificial intelligence technology, and federal agencies are rumored to be part of that effort. While a contract with Open AI has yet to be confirmed, the Food and Drug Administration is suggesting that AI will be a part of its operations sooner rather than later. The announced an "aggressive timeline" to deploy artificial intelligence internally immediately, with full integration across all FDA centers by June 30, following the completion of a new generative AI pilot for...

WASHINGTON — U.S. health regulators announced plans Tuesday to phase out ingestible fluoride supplements sometimes used to strengthen children’s teeth, opening a new front in Health Secretary Robert F. Kennedy Jr.’s effort against a mainstay of dental care. The Food and Drug Administration said it will conduct a scientific review of the children’s products by late October with the aim of removing them from the market. It was not immediately clear whether the agency planned to formally ban the supplements or simply request that companies withdraw them. The products targeted...

Op-ed views and opinions expressed are solely those of the author. Biotech advancements often fac e delays due to bureaucracy, hindering the development of necessary therapies. Now is the time for us to overhaul the archaic procedural measures, including the Food and Drug Administration’s (FDA) outdated policies and procedures. If we continue to permit bureaucracy to impede the advancement of science, then people will continue to die waiting for therapeutic advances – and that is unacceptable. With over 30 million Americans suffering from rare diseases, 95% of whom lack approved...

The U.S. Food and Drug Administration announced Friday it has granted three new color additive petitions to expand the available colors from natural sources that can be safely used in food manufacturing. “Today we take a major step to Make America Healthy Again,” Kennedy said in a Friday news release. "For too long, our food system has relied on synthetic, petroleum-based dyes that offer no nutritional value and pose unnecessary health risks. We’re removing these dyes and approving safe, natural alternatives — to protect families and support healthier choices.” In...

Tomatoes, snack mix, baked beans and a brand of tattoo ink were among the several food and drug items recalled by the Food and Drug Administration this month. If you're not aware of what's currently being recalled for May, here is what you need to know. FDA recalls: Here's a list of what was pulled from shelves in May 2025 so far • Fresh & Ready Foods, Fresh Take Crave Away, City Point Market Fresh Food to Go ready-to-eat sandwiches and snack items: Recalled for potential listeria monocytogenes contamination. •...

Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Yahoo is using AI to generate takeaways from this article. This means the info may not always match what's in the article. Reporting mistakes helps us improve the experience. Generate Key Takeaways...

Authored by Zachary Stieber via The Epoch Times (emphasis ours), The Food and Drug Administration (FDA) is planning to roll out artificial intelligence across the agency following a successful pilot program. FDA Commissioner Dr. Marty Makary has directed all FDA centers to immediately start using artificial intelligence (AI) and fully integrate it by the end of June, the FDA said in a May 8 statement. By June 30, all centers will use what the agency described as a “common, secure generative AI system integrated with FDA’s internal data platforms.” “I...